FSD Pharma Inc. is a pharmaceutical company based in Toronto, Canada, that specializes in research and development. The company's lead candidate, FSD-201, is currently undergoing Phase II clinical trials for the treatment of COVID-19. In addition, FSD Pharma is working on developing two other innovative treatment options for neuropsychiatric disorders and multiple sclerosis.